Trial Profile
A study of tumor-infiltrating lymphocyte in patients with platinum resistant ovarian cancer
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 20 Dec 2017
Price :
$35
*
At a glance
- Drugs Tumour infiltrating lymphocytes Iovance Biotherapeutics/University of Texas M.D. Anderson Cancer Center (Primary)
- Indications Ovarian cancer
- Focus Therapeutic Use
- 20 Dec 2017 New trial record